Rick Livesey

Rick Livesey is currently serving as the Chief Executive Officer at Talisman Therapeutics Limited and GEN2 NEUROSCIENCE LTD. Prior to this, Rick held various senior positions in the field of neuroscience research at companies like Biogen. Rick has an impressive educational background, with a BSc in Neurobiology and Anatomy from University College Cork and an MB/PhD in Medicine specializing in neuroscience from the University of Cambridge. Throughout their career, Rick has also held academic positions at institutions like UCL, University of Cambridge, and Harvard Medical School.